Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 10/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TACR1 | P25103 | 1/20 | 0.31 |
| ▸ | TACR3 | P29371 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6596980 | 0.89 | TACR2 (0.33) | TACR2DRD2DRD4DRD3 | |
| SCHEMBL6594882 | 0.89 | SMN1; SMN2 (0.37) | DRD2DRD4DRD3 | |
| SCHEMBL6593625 | 0.89 | CHRM1 (0.39) | — | |
| SCHEMBL6597750 | 0.89 | MEN1 (0.35) | TACR2DRD2DRD4DRD3 | |
| SCHEMBL6596344 | 0.88 | TACR2 (0.33) | TACR2DRD2DRD4DRD3LMNA | |
| SCHEMBL6598850 | 0.88 | TACR2 (0.33) | TACR2DRD2DRD4DRD3 | |
| SCHEMBL6596349 | 0.88 | TACR2 (0.33) | TACR2DRD2DRD4DRD3LMNA | |
| SCHEMBL6596824 | 0.87 | CHRM1 (0.35) | DRD2DRD4DRD3 | |
| SCHEMBL6596243 | 0.87 | MAPT (0.34) | TACR2DRD2DRD4DRD3HTT | |
| SCHEMBL6592535 | 0.86 | HRH1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888338-A1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997030991-A1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-28 | — | — | WO | disclosed |